An article describing CSCS, its Expert Community, and recent work to expand the project’s scope to include Chinese legislation was published in Scrip Regulatory Affairs on January 9th.
“The life sciences industry is a global one with multinational companies setting up sites in numerous countries to carry out local research and development. This localization of R&D into selected markets has many benefits but it brings with it the complex challenge of adjusting existing corporate business processes to comply with local regulations. As companies continue to open new sites across an increasing number of countries, the number of different sets of regulations that have to be complied with also increases.”
Read the full article here.